a, humanized monoclonal antibody, FDA-approved immunotherapy that treats over 15 types of cancer—including NSCLC, melanoma, and TNBC—by blocking the PD-1 receptor to help the immune system destroy tumor cells.
a, humanized monoclonal antibody, FDA-approved immunotherapy that treats over 15 types of cancer—including NSCLC, melanoma, and TNBC—by blocking the PD-1 receptor to help the immune system destroy tumor cells.
Reviews
There are no reviews yet.